Novel ECM Promotes Rapid Stem Cell-Derived Cardiomyocyte Maturation
Join StemBioSys for this webinar on rapid maturation of plated cardiomyocytes
Date: Thursday, July 15, 2021
Time: 4:00 PM 5:00 PM
Travis J. Block, PhD, Chief Technology Officer, StemBioSys
Todd Herron, PhD, Cardiovascular Regeneration Core Director and Associate Research Scientist, Molecular and Integrative Physiology and Internal Medicine, University of Michigan Medical School and a founder of Cartox
iPSC-derived cardiomyocytes grown on CELLvo™ Matrix Plus rapidly and spontaneously mature and behave as they do in the human body. StemBioSys CELLvo™ Matrices are easy to use and fit into existing workflows. iPSC-derived somatic cells require an appropriate ECM for biologically-relevant function and CELLvo™ Matrices provide an appropriate microenvironment for iPSC-derived cells to achieve maturity in vitro.
CELLvo Plating Protocol Available from FUJIFILM Cellular Dynamics
iCell® Cardiomyocytes2 are cardiac myocytes derived from human induced pluripotent stem cells (iPSC). These cardiomyocytes have been optimized for faster recovery from cryopreservation and can be used in a myriad of functional applications.
A recent article by Block et al. in Nature Scientific Reports indicates that iCell Cardiomyocytes2 have enhanced functional and structural benefits following culture on CELLvo™ Matrix Plus plates for seven days. The available FCDI application protocol details the steps for plating iCell Cardiomyocytes2 on the CELLvo Matrix Plus plates.